Search clinical trials for: Somatropin (rDNA origin)

Total 2123 results

GeneScience Pharmaceuticals Co., Ltd.
Children's Hospital of Fudan University; The First Hospital of Jilin University and other collaborators

Unknown

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Small for Gestational Age Infant

China
HanAll BioPharma Co., Ltd.

Completed

Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers (HL-032)

Growth Hormone Deficiency

Korea, Republic of
Pfizer

Completed

Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age

Fetal Growth Retardation

France
Pfizer

Completed

Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

Small for Gestational Age (SGA)
Novo Nordisk A/S

Terminated

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis (OPPORTUNITY)

Chronic Kidney Disease | End-Stage Renal Disease

France, United States, Spain, United Kingdom, Canada, Denmark, Germany, Sweden, Argentina, India, Israel, Russian Federation, Hungary, Turkey, Italy, Poland, South Africa, China, Brazil, Portugal, Puerto Rico
Sandoz

Completed

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

Small for Gestational Age

Belgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
Novo Nordisk A/S

Enrolling by invitation

French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

Noonan Syndrome

France
Pfizer

Completed

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Short Stature Born Small for Gestational Age (SGA)

Japan
Pfizer

Completed

Long Term Use of Somatropin in Patients Small for Gestational Age

Small for Gestational Age
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients (DART-REIN)

Acute Kidney Injury | Renal Transplantation

France
Atlas Biomed

Terminated

Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease

Parkinson Disease | Genetic Predisposition

Russian Federation
Atlas Biomed

Completed

Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Genetic Predisposition | Metagenome

Russian Federation
GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology

Completed

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (Phase 1)

Growth Hormone Deficiency
Sanofi

Completed

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

Diabetes Mellitus

United States
Cedar Associates LLC
Pathwork Diagnostics

Terminated

A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

Neoplasm Metastasis

United States
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin) (SEPAGE)

Infant, Small for Gestational Age

France
Ferring Pharmaceuticals

Terminated

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device (ZOMAXEPT)

Growth Hormone Deficiency | Turner's Syndrome

France
Pfizer

Completed

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age (AGA)

Infant, Very Low Birth Weight | Growth Hormone Therapy

Germany
Allenmore Hospital

Completed

The Comparison of Pulse Oximetry, End-tidal Capnometry, and Integrated Pulmonary Index (IPI)

Postoperative Care

United States
Novo Nordisk A/S

Completed

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

Prader-Willi Syndrome | Genetic Disorder

Germany, Denmark, Switzerland
British Columbia Cancer Agency

Not yet recruiting

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer (PATH)

Head and Neck Cancer
Ajman University

Completed

Microbial Profiling in Pockets Related to Chronic Periodontitis Patients Using 16s RNA Metagenomics Sequencing

Periodontal Diseases

United Arab Emirates
King Faisal Specialist Hospital & Research Center

Completed

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) (GLUCOSE-in-PN)

Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition

Saudi Arabia
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Completed

A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA

Small for Gestational Age Infant

China
University Hospital, Bordeaux

Recruiting

CML Pediatric ITK Response According to Molecular Identification at Diagnosis (CML Piramid)

Chronic Myeloid Leukemia

France
Université Libre de Bruxelles
DESCARTES Working Group On Transplantation

Completed

TOlerance MOlecular and Genome-wide Studies With Renal Allograft Recipient Material (TOMOGRAM)

Kidney Transplantation
University of Campania "Luigi Vanvitelli"

Unknown

Network Medicine, Epigenetics and Obesity (NEWTON)

Obesity | Type2 Diabetes
Symbios Orthopedie SA

Not yet recruiting

A Post-market Observational ORIGIN® CR Clinical Study

Total Knee Replacement
University of Virginia

Unknown

UVA Brain and Aortic Aneurysm Study (BAAS)

Intracranial Aneurysm | Abdominal Aortic Aneurysm

United States
University of Erlangen-Nürnberg Medical School

Completed

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin (ISS)

Idiopathic Short Stature

Germany
Novo Nordisk A/S

Completed

An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin® (GET)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Germany
Pfizer

Completed

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety (VOLUME)

Diabetes Mellitus

United States, Germany, Sweden, United Kingdom, Puerto Rico
AIDS Malignancy Consortium
National Cancer Institute (NCI); The Emmes Company, LLC

Terminated

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Lymphoma | Nonneoplastic Condition

United States
University of Toronto
University Health Network, Toronto

Terminated

Study of Tumor RNA Disruption Assay™ (RDA) (RnaDx)

Breast Neoplasms

Canada
Signature Orthopaedics
The Cleveland Clinic

Recruiting

Origin Stem and Logical Cup Post Market Clinical Follow-up

Hip Disease

United States
Secret of Youth

Completed

Natural Gels for Treatment of Plaque Psoriasis

Parapsoriasis

Israel
Institut Universitari Dexeus

Terminated

Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients (FUNDEX001)

Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer

Spain
Novo Nordisk A/S

Completed

French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Growth Hormone Disorder | Adult Growth Hormone Deficiency

France
LG Life Sciences

Completed

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Growth Hormone Deficiency | Chronic Renal Failure | Turner Syndrome | Infant, Small for Gestational Age | Short Stature, Idiopathic

Korea, Republic of
Novo Nordisk A/S

Completed

Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

Turkey
Novo Nordisk A/S

Completed

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Foetal Growth Problem | Small for Gestational Age

Spain
Novo Nordisk A/S

Completed

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Foetal Growth Problem | Small for Gestational Age

Netherlands
Sanofi

Completed

MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children

Fetal Growth Retardation

France
Pfizer

Terminated

A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury (GHD)

Brain Injuries | Growth Hormone Deficiency Dwarfism

United States
Eli Lilly and Company

Completed

Growth Hormone Treatment in Short Children Born Small for Gestational Age

Infant, Small for Gestational Age

Germany
Children's National Research Institute

Active, not recruiting

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Growth Disorders

United States
Novo Nordisk A/S

Completed

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

Foetal Growth Problem | Small for Gestational Age

Japan
Novo Nordisk A/S

Completed

Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature

Growth Disorder | Idiopathic Short Stature

Korea, Republic of
Novo Nordisk A/S

Completed

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) (ANSWER)

Hypopituitarism | Growth Hormone Disorder | Pituitary Dwarfism

United States
Novo Nordisk A/S

Completed

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

United States

Search clinical trials for: Somatropin (rDNA origin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations